Mannatech,
Incorporated
(NASDAQ: MTEX),
the leading innovator and provider of nutritional supplements and skin
care products based on Real
Food Technology® solutions, has announced a
restructuring of its U.S. operations, which impacts 64 employees across
various departments.
The strategic move also eliminates 34 other open positions and
redistributes critical responsibilities to existing teams within
Mannatech U.S. headquarters.
"Persistent challenges in the economy have forced many companies to take
decisive measures toward keeping expenses in line with revenues,” said
Dr. Robert Sinnott, co-CEO and chief science officer of Mannatech.
"We regret this difficult decision for those who will no longer be part
of our team. For several months, our senior management team has honed a
plan to reposition Mannatech in the marketplace, rebuild profitability
and thereby create enduring shareholder value.”
Mannatech’s Board of Directors and Executives believe this action was
necessary in order to maintain focus on critical business objectives in
2011 and beyond, while also taking strong steps to restore profitability
and generate positive cash flow. The move will produce a more effective
and resourceful organization while the company improves domestic sales
and drives international growth.
"This restructuring has been carefully planned and will provide
Mannatech more than $12 million in savings on an annualized basis,” said Steve
Fenstermacher, co-CEO and chief financial officer of Mannatech.
"The cost savings include significant operating expense reductions
across virtually every functional area of the company. Mannatech plans
to take a reserve of approximately $700,000 in the second quarter
related to severances and restructuring costs.”
Following this restructuring, Mannatech has 273 U.S. employees and an
additional 152 employees abroad who serve 21 countries worldwide.
Collectively, these employees serve an Associate base of almost 400,000
independent sales representatives.
For more information, visit Mannatech.com.
About Mannatech
Mannatech, Incorporated, develops high-quality health, weight and
fitness, and skin care products that are based on the solid foundation
of nutritional science and development standards. Mannatech is dedicated
to its platform of Social Entrepreneurship based on the foundation of
promoting, aiding and optimizing nutrition where it is needed most
around the world. Mannatech’s proprietary products are available through
independent sales Associates around the globe including the United
States, United Kingdom, Canada, South Africa, Australia, New Zealand,
Austria, Denmark, Germany, Norway, Sweden, the Netherlands, the United
Kingdom, Japan, Taiwan, Singapore, Estonia, Finland, the Republic of
Ireland, Czech Republic, the Republic of Korea and Mexico. For more
information, visit Mannatech.com.
Please note: This release contains "forward-looking statements”
within the meaning of Section 27A of the Securities Act of 1933, as
amended, Section 21E of the Securities Exchange Act of 1934, as amended,
and the Private Securities Litigation Reform Act of 1995. These
forward-looking statements generally can be identified by use of phrases
or terminology such as "intend” or other similar words or the negative
of such terminology. Similarly, descriptions of Mannatech’s objectives,
strategies, plans, goals or targets contained herein are also considered
forward-looking statements. Mannatech believes this release should be
read in conjunction with all of its filings with the United States
Securities and Exchange Commission and cautions its readers that these
forward-looking statements are subject to certain events, risks,
uncertainties and other factors. Some of these factors include, among
others, Mannatech’s inability to attract and retain Associates and
Members, increases in competition, litigation, regulatory changes and
its planned growth into new international markets. Although Mannatech
believes that the expectations, statements and assumptions reflected in
these forward-looking statements are reasonable, it cautions readers to
always consider all of the risk factors and any other cautionary
statements carefully in evaluating each forward-looking statement in
this release, as well as those set forth in its latest Annual Report on
Form 10-K and Quarterly Report on Form 10-Q, and other filings filed
with the United States Securities and Exchange Commission, including its
current reports on Form 8-K. All of the forward-looking statements
contained herein speak only as of the date of this release.
